LILRB3 and neoplasm: We used RT-qPCR to validate the differential expression of the five genes most strongly linked to inflammation and tumor immune responses: chemokine Ccl7, cytokine Csf2/GM-CSF, cytokine receptors Il4r and Il18r1, and inhibitor of antitumor immunity through antigen presentation Lilrb3.